KELSEYVILLE, CA, April 04, 2018 -- Vet Online Supply, Inc. (OTC PINK:VTNL) (the Company), announces today that its new line of CBD Pet Oral Sprays has landed its first wholesale distribution order for $6.5M.
|
|||||
Daniel Rushford, CEO and Chairman, stated “The Company started receiving orders for our new Oral Pet Sprays on March 26, 2018 and is now selling its CBD Pet Oral Sprays and anticipates the largest revenue stream from these two products as compared to our other CBD Pet Treats and Pet Drops. A major CBD wholesaler has agreed to purchase $6.5M on Oral Pet Sprays from Vet Online Supply Inc. during the next 12 months. Vet Online Supply is allowing the wholesaler an exclusive agreement to purchase and place our CBD Pet products in west coast based marijuana dispensaries through April 3, 2019.”
The company’s Pain & Joint Support Oral Pet Spray and our Anti-Stress & Calming Oral Pet Spray are available in an 8ml/.25 ounce concentrated formula spray bottle that is environmentally friendly. The retail cost for the oral sprays are $47.99 each and available at this time only through our online retail website.
ABOUT VET ONLINE SUPPLY:
Vet Online Supply Inc. is a small US based online retail reseller of proprietary veterinary products to enhance the pets health and well being. The goal of "Vet Online Supply" is to provide the $38B industry with value priced, superior quality holistic pet products.
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The Company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
Contact: Meridian Consulting 323-364-3793


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Anta Sports Expands Global Footprint With Strategic Puma Stake
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 



